Healthcare Dialogues

Association of International Research-Based Pharmaceuticals Manufacturers (SIFFA) invites you to a conference “Healthcare Dialogues: Opportunities, Challenges, and Solutions,” on October 4th in Riga.

This event, presented in an innovative and interactive format, will feature four distinct dialogues. Each dialogue will involve two participants who will identify challenges and collaboratively seek solutions to specific questions. The discussions will aim to find common ground across various healthcare sectors, exploring points of cooperation and differences of opinion.

The keynote dialogue between between Minister of Health Hosams Abu Meri and Head of the Budeget and Finance Committee of Saeima Jānis Reirs will address key questions about investment attraction and its role in the broader economic and health contexts at the national level. The second session will compare the approaches of Latvia and Czechia in developing performance-based healthcare strategies. The third dialogue will showcase success stories, good practices and challenges from the doctor-patient perspective. Finally, the closing dialogue will seek to explore the synergies between innovations in pharmaceuticals and the broader digitalisation landscape.

The conference is also be available online:

Conference “Healthcare Dialogues: Opportunities, Challenges and Solutions”
October 4 | Riga

9:00-10:00

Registration, coffee break and networking

10:00-10:15

Opening speeches

Liene SILIŅA, Chairwoman of the board, Association of International Research-Based Pharmaceuticals Manufacturers
Nathalie MOLL, Director General of European Federation of Pharmaceutical Industries and Associations

10:15-11:00

Dialogue 1: Investments in healthcare and economy: Where is the middle ground?
Participants:

Jānis REIRS, Head of Budget and Finance Committee of Saeima
Hosams ABU MERI, Minister of Health of Latvia

11:00-11:45

Dialogue 2: Performance based healthcare: Examples and opportunities
Participants:

Āris KASPARĀNS, Director, Latvian National Health Service
Tomáš BORAN, Director of the State Institute for Drug Control in Czechia

11:45-13:00

Lunch break

13:00-13:45

Dialogue 3: Doctor and patient perspectives: Experiences, successes and challenges
Participants:

Anna KLĒŠMITE-BLŪMA, Member of the board, Latvian Junior Doctors Association
Miķelis BENDIKS, Latvian Association of Bone, Joint and Connective Tissue Diseases

13:45-14:30

Dialogue 4: Innovations in digitalization and pharmaceuticals: What is the synergy?
Participants:

Vladislava MARĀNE, Director, Association of International Research-Based Pharmaceuticals Manufacturers
Emīls SJUNDJUKOVS, Co-founder, “Longenesis”

14:30-15:00

Closing remarks, coffee break and networking